Clinical Trial Update: T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam [Phase 4]

View source ↗

Summary

Phase 4 trial comparing three days of ertapenem to three days of ampicillin-sulbactam for intra-abdominal infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection

Drugs mentioned

• Ampicillin-sulbactam (Ampicillin-sulbactam)
• ERTAPENEM (ertapenem)

Snippet

Sponsor: University of Bologna | Conditions: Intra-Abdominal Infection | Phase 4 | Status: COMPLETED